Ekso Bionics (EKSO) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts EKSO Hot Sheet
Join SI Premium – FREE
Ekso Bionics (NASDAQ: EKSO) reported Q2 EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $5 million versus the consensus estimate of $5.15 million.
For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Starts APL Apollo Tubes Ltd (APAT:IN) at Buy
- TD Cowen Upgrades Flagstar Bank (FLG) to Buy
- Morgan Stanley Downgrades Prosperity Bancshares (PB) to Equalweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
